High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation

Eytan Mor, Burt R. Meyers, Ozgur Yagmur, Keiji Kishikawa, Patricia A. Sheiner, Sukru Emre, Myron E. Schwartz, Charles M. Miller

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences